Birmingham research brings hope for spinal cord injury treatment
Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord. Their research, published in Clinical and Translational Medicine, demonstrates that...New spinout to speed development for ocular disease and eye trauma therapeutics
The University of Birmingham has created a new spinout, Healome TherapeuticsLtd, to commercially deploy a platform that delivers a ‘pro-healing’ microenvironment for the leading causes of preventable blindness. The company’s leading application will be in ocular...
Urine test for bladder cancer could replace 1000s of invasive cystoscopies given each year
Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming procedures to diagnose the disease. The test will use highly sensitive...Specialist molecular diagnostic company lands in Birmingham
Infectious disease diagnostics company Genetic Signatures has joined the BioHub Birmingham® as the launchpad for a planned further expansion into Europe, the Middle East and Africa. The BioHub is the first physical footprint within the UK and Europe for Genetic...New spinout brings ‘omics’ to chemical safety
The University of Birmingham has formed new spinout company, Michabo Health Science Ltd, to provide fast, reliable predictions of whether chemicals are potentially hazardous to human health or the environment. The company will use new methods developed by researchers...
